Old Web
English
Sign In
Acemap
>
Paper
>
Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience
Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience
2021
Marwa Bin Morya
Mohammed A. Marei
Imran K Tailor
Abdullah M. Alrajhi
Adel Alnakhli
Foud Alnajjar
Mohammed S. Alnoamani
Hassan Alshehri
Ibraheem H Motabi
Nawal AlShehry
Mansour Alfayez
Keywords:
salvage treatment
Single Center
Oncology
Refractory
Polatuzumab vedotin
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]